ArriVent BioPharma
AVBP
AVBP
120 hedge funds and large institutions have $810M invested in ArriVent BioPharma in 2025 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 40 increasing their positions, 35 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
14% more capital invested
Capital invested by funds: $712M → $810M (+$97.8M)
2.07% more ownership
Funds ownership: 95.07% → 97.14% (+2.1%)
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
Holders
120
Holding in Top 10
5
Calls
$7.43M
Puts
$12K
Top Buyers
| 1 | +$9.54M | |
| 2 | +$8.38M | |
| 3 | +$6.8M | |
| 4 |
Goldman Sachs
New York
|
+$6.46M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$6.16M |
Top Sellers
| 1 | -$12.9M | |
| 2 | -$11.6M | |
| 3 | -$7.77M | |
| 4 |
Morgan Stanley
New York
|
-$6.13M |
| 5 |
Franklin Resources
San Mateo,
California
|
-$4.73M |
